ID   TA-1 [Human leukemia]
AC   CVCL_QX04
DR   Wikidata; Q54971644
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8395908;
CC   Population: Japanese.
CC   Doubling time: 96-120 hours (PubMed=8395908).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
RX   PubMed=8395908;
RA   Tanabe, Satoru
RA   Fukuhara, Shiro
RA   Yoneda, Tomoya
RA   Ohmori, Katsuyuki
RA   Nosaka, Tetsuya
RA   Hatanaka, Masakazu
RA   Okuma, Minoru
RT   "Characterization of a novel biphenotypic leukemia cell line, TA-1,
RT   with myeloperoxidase and inducible cytoplasmic mu chain: altered
RT   rearrangement patterns of antigen receptor genes.";
RL   Int. J. Hematol. 57:229-243(1993).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//